Indivior Pharmaceuticals Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while W.R. Berkley Corporation Common Stock trades at $74.93 (market cap $27.40B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 6.8× Indivior Pharmaceuticals Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| INDV | WRB | |
|---|---|---|
Market Cap | $4.03B | $27.40B |
Volume | 2,781,171 | 2,015,378 |
Sector | Health | Financials |
52-Week High | $41.83 | $78.10 |
52-Week Low | $24.09 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.32B | $27.64B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →